Related Experiment Videos

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation

Akihiro Ito1, Yoshiharu Kawaguchi, Chun-Hsiang Lai

  • 1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA.

The EMBO Journal
|November 12, 2002
PubMed

Insights

The tumor suppressor p53

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • p53 is a tumor suppressor protein crucial for cellular stress response.
  • Post-translational modifications, like acetylation, regulate p53 stability and function.
  • MDM2 negatively regulates p300/CBP-mediated p53 acetylation.

Purpose of the Study:

  • To investigate the role of MDM2 in p53 deacetylation.
  • To identify the mechanism by which MDM2 influences p53 acetylation status.

Main Methods:

  • Investigated the interaction between MDM2 and histone deacetylase 1 (HDAC1).
  • Assessed p53 deacetylation in cells expressing wild-type and mutant HDAC1.
  • Analyzed p53 acetylation, stability, and downstream target gene induction (p21, MDM2) in fibroblasts.

Main Results:

  • MDM2 recruits HDAC1 to deacetylate p53 at known acetylated lysine residues.
  • HDAC1 complex binds MDM2 independently of p53.
  • Dominant-negative HDAC1 mutant restores p53 acetylation, enhancing p53 levels and target gene induction.
  • Wild-type HDAC1 and MDM2 act synergistically to deacetylate p53.

Conclusions:

  • p53 acetylation promotes its stability and function.
  • MDM2-recruited HDAC1 promotes p53 degradation by removing acetyl groups.
  • p53 acetylation prevents MDM2-dependent ubiquitylation, thereby stabilizing p53.

Related Concept Videos